146 related articles for article (PubMed ID: 7924634)
21. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
22. [Detection of thyroid stimulating antibodies and TSH binding inhibitor immunoglobulins in patients with thyroid diseases and its clinical applications].
Liu C; Yin F; Zhang Z
Zhonghua Nei Ke Za Zhi; 1995 Feb; 34(2):105-7. PubMed ID: 7796654
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of functional thyrotropin receptor antibodies in Serbian patients with Graves' orbitopathy.
Sarić Matutinović M; Diana T; Nedeljković Beleslin B; Ćirić J; Žarković M; Kahaly GJ; Ignjatović S
J Endocrinol Invest; 2022 Jan; 45(1):189-197. PubMed ID: 34324163
[TBL] [Abstract][Full Text] [Related]
24. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
Mori Y; Matoba N; Miura S; Sakai N; Taira Y
World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
[TBL] [Abstract][Full Text] [Related]
25. Generation of a transgenic animal model of hyperthyroid Graves' disease.
Kim-Saijo M; Akamizu T; Ikuta K; Iida Y; Ohmori K; Matsubara K; Matsuda Y; Suzuki M; Matsuda F; Nakao K
Eur J Immunol; 2003 Sep; 33(9):2531-8. PubMed ID: 12938229
[TBL] [Abstract][Full Text] [Related]
26. [Clinical value of the determination of TSH-binding inhibitory immunoglobulins (TBII) by a radioreceptor assay].
Heberling HJ; Bierwolf B; Lohmann D
Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):301-6. PubMed ID: 2879721
[TBL] [Abstract][Full Text] [Related]
27. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
28. The relationships between serum T3 index, thyroid volume, and thyroid stimulating, TSH receptor binding and thyroid growth stimulating antibodies in untreated Graves' disease.
Bliddal H; Hegedüs L; Hansen JM; Bech K; van der Gaag R; Drexhage HA
Clin Endocrinol (Oxf); 1987 Jul; 27(1):75-84. PubMed ID: 2888551
[TBL] [Abstract][Full Text] [Related]
29. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation.
Schott M; Feldkamp J; Bathan C; Fritzen R; Scherbaum WA; Seissler J
Horm Metab Res; 2000 Oct; 32(10):429-35. PubMed ID: 11069209
[TBL] [Abstract][Full Text] [Related]
30. A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy.
Kung AW; Jones BM
J Clin Endocrinol Metab; 1998 Feb; 83(2):514-8. PubMed ID: 9467567
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
Yokoyama N; Izumi M; Katamine S; Nagataki S
J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
[TBL] [Abstract][Full Text] [Related]
32. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
[TBL] [Abstract][Full Text] [Related]
33. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin.
Mukuta T; Tamai H; Oshima A; Morita T; Matsubayashi S; Fukata S; Kuma K
Clin Endocrinol (Oxf); 1994 Feb; 40(2):215-9. PubMed ID: 7907955
[TBL] [Abstract][Full Text] [Related]
34. TSH-receptor antibodies in hypothyroid Graves' disease.
Konishi J; Kasagi K; Hidaka A; Takeuchi R; Iida Y; Nakamura H
Exp Clin Endocrinol; 1991 May; 97(2-3):303-7. PubMed ID: 1680728
[No Abstract] [Full Text] [Related]
35. Bioassays for TSH-receptor autoantibodies: an update.
Lytton SD; Kahaly GJ
Autoimmun Rev; 2010 Dec; 10(2):116-22. PubMed ID: 20807591
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between OX40/4-1 BB (CD134/CD137) costimulatory molecules expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease].
Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):133-40. PubMed ID: 16232366
[TBL] [Abstract][Full Text] [Related]
37. The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease.
Cho SW; Bae JH; Noh GW; Kim YA; Moon MK; Park KU; Song J; Yi KH; Park do J; Chung JK; Cho BY; Park YJ
PLoS One; 2015; 10(12):e0144599. PubMed ID: 26650844
[TBL] [Abstract][Full Text] [Related]
38. Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Mori K; Hori H; Abe K
J Endocrinol Invest; 1996 Nov; 19(10):682-6. PubMed ID: 9007700
[TBL] [Abstract][Full Text] [Related]
39. Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies.
Diana T; Wüster C; Kanitz M; Kahaly GJ
J Endocrinol Invest; 2016 Oct; 39(10):1159-65. PubMed ID: 27197966
[TBL] [Abstract][Full Text] [Related]
40. Thyrotropin (TSH) receptor modulation by specific TSH receptor antibodies in Graves' disease.
de Bruin TW; Bussemaker JK; Heidema J; Hermans J; van der Heide D
J Clin Endocrinol Metab; 1988 Oct; 67(4):676-81. PubMed ID: 2901428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
